Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Proto Script Pharmaceutical's Pretax Margin % or its related term are showing as below:
PSCR's Pretax Margin % is not ranked *
in the Business Services industry.
Industry Median: 5.3 * Ranked among companies with meaningful Pretax Margin % only.
Proto Script Pharmaceutical (OTCPK:PSCR) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Proto Script Pharmaceutical Pretax Margin % Related Terms
Proto Script Pharmaceutical Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PSCR vs EXCC, NXES, PRZM: Pretax Margin % Comparison
For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Proto Script Pharmaceutical Pretax Margin % vs Business Services Industry
For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Proto Script Pharmaceutical's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proto Script Pharmaceutical (PSCR) has a Pretax Margin % of -112.70% as of Sep. 2017. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's Pretax Margin % too high?
Proto Script Pharmaceutical's current Pretax Margin % is -112.70%.
How does Proto Script Pharmaceutical's Pretax Margin % compare to EXCC and NXES?
Proto Script Pharmaceutical's Pretax Margin % of -112.70% can be compared against companies in the Business Services industry. The industry median Pretax Margin % is 5.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Business Services company?
The median Pretax Margin % among Business Services companies is 5.30, based on 1,071 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Proto Script Pharmaceutical and its competitors. For the Business Services industry, the median Pretax Margin % is 5.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proto Script Pharmaceutical's current Pretax Margin % is -112.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current Pretax Margin % of -112.70%. The current Pretax Margin % is -112.70%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current Pretax Margin % is -112.70% as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PSCR has been successfully added to your 
